相关实验视频

Updated: Jun 27, 2025

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients

Published on: February 7, 2021

EMP2 作为一种功能性生物标志物,用于抗化疗的三阴性乳腺癌

Ann M Chan^1,2, Brian Aguirre¹, Lucia Liu¹

¹Department of Pathology Lab Medicine, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, USA.

|April 27, 2024

概括

表皮膜蛋白2 (EMP2) 预测了接受化疗的三阴性乳腺癌 (TNBC) 患者的不良结果. 用dcetaxel针对EMP2降低了瘤负担,这表明TNBC的新治疗策略.

科学领域:

在瘤学瘤学.
分子生物学分子生物学

背景情况:

三阴性乳腺癌 (TNBC) 呈现出侵略性行为和低生存率.
目前用于TNBC的化疗缺乏具体的点,导致结果不理想.

研究的目的:

研究表皮膜蛋白2 (EMP2) 作为TNBC化疗反应的预后生物标志物.
在TNBC模型中评估针对EMP2的治疗潜力.

主要方法:

在TNBC患者中探索EMP2表达的转录和蛋白质水平.
评估了EMP2表达和基于税的化疗后患者存活率之间的相关性.
在TNBC模型中研究了合并EMP2向和多塞塔克塞尔治疗的疗效.

主要成果:

高EMP2表达与TNBC患者的整体存活率差相关,这些患者接受了基于taxan的化疗.
结合EMP2向和多塞塔克塞尔治疗在临床前TNBC模型中显著降低了瘤负载.

结论:

在TNBC中,EMP2作为化疗反应的预后生物标志物.
向EMP2为抗化疗性TNBC提供了一个潜在的治疗策略.

关键词:

生物标志物生物标志物化学疗法化疗化疗皮质膜蛋白 2 皮质膜蛋白 2 三重阴性乳腺癌是什么

更多相关视频

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Validated Immunochemical Assay for Comprehensive Determination of the Human Epidermal Growth Factor Receptor 2 Released from and Bound to Cells

Published on: May 9, 2025

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Published on: July 25, 2020

相关概念视频

Mitogens and the Cell Cycle

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...